GL 243
Alternative Names: GL-243Latest Information Update: 28 Apr 2021
At a glance
- Originator Genisphere
- Class Anthracyclines; Antineoplastics; Cytostatic antibiotics; Doxorubicins; Immunoconjugates; Small molecules
- Mechanism of Action DNA intercalators; Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Ovarian cancer
Most Recent Events
- 28 Apr 2021 No recent reports of development identified for preclinical development in Ovarian-cancer in USA
- 17 Mar 2016 Preclinical trials in Ovarian cancer in USA (unspecified route) (Genisphere pipeline,